Coagulex, Inc. — Form D
Coagulex, Inc. of HOUSTON, TX, a company, filed a Form D exempt-offering notice with the SEC on 2018-02-13. The offering totals $500K, of which $263K was reported sold. Industry: Other Health Care.
Offering
- Filed: 2018-02-13
- Form: D
- Accession: 0001730850-18-000001
- Industry: Other Health Care
- Exemptions: 06b
- Total offering: $500K
- Amount sold: $263K
- Remaining: $238K
- Minimum investment: $25K
- Investors: 4
- Date of first sale: 2018-02-01
- Security types: equity, debt
- Revenue range: Decline to Disclose
- SEC file number: 021-305490
Issuer
- Name: Coagulex, Inc.
- CIK: 0001730850
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Address: 1120 NASA PARKWAY, SUITE 600, HOUSTON, TX, 77058
- Phone: 832-455-3173
Officers, directors & promoters (4)
| Name | Role | Location |
|---|
| Brijesh Jerome Gill | Director | Houston, TX |
| Elvin Jerome Pederson | Director | Houston, TX |
| Jeffery Sheldon | Director | Galveston, TX |
| Jeffery Sheldon | Executive Officer | Galveston, TX |
More